Sheril Mathew
NPI 1023488913ActiveIndividual· Clinical Nurse Specialist· Edmond, OK
Clinical Nurse Specialist with Oklahoma Arthritis Center, P.C., practicing in Edmond, Oklahoma. Their prescriptions cost Medicare Part D more than their services did: $1,233,159 for 2,644 claims, against $60,096 paid for services in 2024. Novartis Pharmaceuticals Corporation was the largest of 8 companies reporting payments in 2025, $267.30 in all, mostly food and beverage.
Overview
| NPI | 1023488913 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Sole proprietor | No |
| NPI issued | Oct 5, 2015 |
| Last updated in NPPES | Mar 24, 2016 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Clinical Nurse Specialist Primary | 364S00000X | R0116015 | OK |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Nurse Practitioner (OK) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 218 |
|---|---|
| Services billed | 3,253 across 59 procedure codes |
| Paid by Medicare | $60,096 |
Part D prescriptions in 2024
| Prescriptions (claims) | 2,644 · 4,288 30-day fills |
|---|---|
| Patients | 253 |
| Total drug cost | $1,233,159 |
| Generic share | 79% of claims |
Education and affiliations
| Graduation year | 2015 |
|---|---|
| Medicare specialty | Nurse Practitioner |
Medical group
- Oklahoma Arthritis Center, P.C.Edmond, OK · 45 clinicians
Industry payments (Open Payments)
- 2025$267.30 · 13 payments from 8 companies
- 2024$288.27 · 6 payments from 3 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novartis Pharmaceuticals Corporation | $63.14 | 3 |
| Ucb, Inc. | $49.09 | 2 |
| Astrazeneca Pharmaceuticals LP | $37.01 | 2 |
| Glaxosmithkline, LLC. | $34.95 | 2 |
| Amgen Inc. | $24.17 | 1 |
What the 2025 payments were for
- Food and Beverage$267.30 · 13 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records